EHMT2

Euchromatic histone-lysine N-methyltransferase 2

PDB rendering based on 2o8j.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols EHMT2 ; BAT8; C6orf30; G9A; GAT8; KMT1C; NG36
External IDs OMIM: 604599 MGI: 2148922 HomoloGene: 48460 ChEMBL: 6032 GeneCards: EHMT2 Gene
EC number 2.1.1.43
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez 10919 110147
Ensembl ENSG00000204371 ENSMUSG00000013787
UniProt Q96KQ7 Q9Z148
RefSeq (mRNA) NM_001289413 NM_001286573
RefSeq (protein) NP_001276342 NP_001273502
Location (UCSC) Chr 6:
31.88 – 31.9 Mb
Chr 17:
34.9 – 34.91 Mb
PubMed search

Euchromatic histone-lysine N-methyltransferase 2 (EHMT2), also known as G9a, is a histone methyltransferase that in humans is encoded by the EHMT2 gene.[1][2][3]

Function

A cluster of genes, BAT1-BAT5, has been localized in the vicinity of the genes for TNF alpha and TNF beta. This gene is found near this cluster; it was mapped near the gene for C2 within a 120-kb region that included a HSP70 gene pair. These genes are all within the human major histocompatibility complex class III region. This gene was thought to be two different genes, NG36 and G9a, adjacent to each other but a recent publication shows that there is only a single gene. The protein encoded by this gene is thought to be involved in intracellular protein-protein interaction. There are three alternatively spliced transcript variants of this gene but only two are fully described.[3]

G9a and G9a-like protein, another histone-lysine N-methyltransferase, catalyze the dimethylated state of H3K9me2. G9a is an important control mechanism of the epigenetic regulation in addiction that occurs in the nucleus accumbens, as it opposes the induction of ΔFosB expression and is suppressed by ΔFosB.[4] G9a exerts opposite effects to that of ΔFosB on drug-related behavior (e.g., self-administration) and synaptic remodeling (e.g., dendritic arborization) in the nucleus accumbens, and therefore opposes ΔFosB's function as well as increases in its expression.[4]

Interactions

EHMT2 has been shown to interact with KIAA0515.[5]

References

  1. Milner CM, Campbell RD (Mar 1993). "The G9a gene in the human major histocompatibility complex encodes a novel protein containing ankyrin-like repeats". The Biochemical Journal 290 (Pt 3): 811–8. PMC 1132354. PMID 8457211.
  2. Tachibana M, Sugimoto K, Fukushima T, Shinkai Y (Jul 2001). "Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3". The Journal of Biological Chemistry 276 (27): 25309–17. doi:10.1074/jbc.M101914200. PMID 11316813.
  3. 1 2 "Entrez Gene: EHMT2 euchromatic histone-lysine N-methyltransferase 2".
  4. 1 2 Nestler EJ (January 2014). "Epigenetic mechanisms of drug addiction". Neuropharmacology. 76 Pt B: 259–268. doi:10.1016/j.neuropharm.2013.04.004. PMC 3766384. PMID 23643695.
  5. Rual JF, Venkatesan K, Hao T, Hirozane-Kishikawa T, Dricot A, Li N, Berriz GF, Gibbons FD, Dreze M, Ayivi-Guedehoussou N, Klitgord N, Simon C, Boxem M, Milstein S, Rosenberg J, Goldberg DS, Zhang LV, Wong SL, Franklin G, Li S, Albala JS, Lim J, Fraughton C, Llamosas E, Cevik S, Bex C, Lamesch P, Sikorski RS, Vandenhaute J, Zoghbi HY, Smolyar A, Bosak S, Sequerra R, Doucette-Stamm L, Cusick ME, Hill DE, Roth FP, Vidal M (Oct 2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.

Further reading

This article is issued from Wikipedia - version of the Wednesday, January 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.